ライフサイエンスコーパス: resistant bacteria

1 ses resistance to colonization by antibiotic-resistant bacteria.

2 subsequent bloodstream infections caused by resistant bacteria.

3 ntial for phage therapy to combat antibiotic-resistant bacteria.

4 al agents to treat people infected with drug-resistant bacteria.

5 , are predominantly active against many drug-resistant bacteria.

6 rtance given the alarming growth of pan-drug-resistant bacteria.

7 cribed risk factors for infections caused by resistant bacteria.

8 ible, for study of infections caused by drug-resistant bacteria.

9 s the main driver for carriage of antibiotic-resistant bacteria.

10 rates of genome rearrangements in radiation-resistant bacteria.

11 were directly attributable to extremely drug-resistant bacteria.

12 les, which could serve as the source of drug-resistant bacteria.

13 iii) the removal of pathogens and antibiotic resistant bacteria.

14 ion of patients colonized by emerging highly resistant bacteria.

15 th potent activity toward Gram-positive drug-resistant bacteria.

16 hat responds to cell-wall alteration in drug-resistant bacteria.

17 r clinical efficacy through the selection of resistant bacteria.

18 ics against the growing number of antibiotic-resistant bacteria.

19 ons, particularly those caused by antibiotic-resistant bacteria.

20 evaluated as adjuvants for the treatment of resistant bacteria.

21 ributes to increased prevalence of multidrug-resistant bacteria.

22 ns, especially in cases involving antibiotic-resistant bacteria.

23 e to find new therapies to combat antibiotic-resistant bacteria.

24 iated infections caused by highly antibiotic-resistant bacteria.

25 ent antibacterial activity towards multidrug-resistant bacteria.

26 y medicine causes the emergence of multidrug resistant bacteria.

27 d (Cas) system into the genome of antibiotic-resistant bacteria.

28 articularly those caused by extensively drug-resistant bacteria.

29 s for the selection and spread of antibiotic-resistant bacteria.

30 e metallopolymer hydrogels to kill multidrug resistant bacteria.

31 atment, toxicity, and selection of multidrug-resistant bacteria.

32 will most limit the emergence and spread of resistant bacteria.

33 new class of antibiotics against multi-drug resistant bacteria.

34 tibacterials are needed to tackle antibiotic-resistant bacteria.

35 antibiotics and selectively kill antibiotic-resistant bacteria.

36 l platform for developing AMPs to treat drug-resistant bacteria.

37 efore help to treat infections of antibiotic resistant bacteria.

38 re needed to treat infections caused by drug-resistant bacteria.

39 ons were to increase and may also select for resistant Bacteria.

40 for development and enrichment of antibiotic resistant bacteria.

41 tive vaccine and the emergence of multi-drug-resistant bacteria.

42 it (ICU) decreases acquisition of antibiotic-resistant bacteria.

43 due to transmission of particular antibiotic-resistant bacteria.

44 s to antibiotics and therapies for multidrug-resistant bacteria.

45 ncing the likelihood of harboring antibiotic-resistant bacteria.

46 for new antimicrobial drugs to combat these resistant bacteria.

47 Pro were more likely to be colonized with FQ-resistant bacteria.

48 s to prevent the spread of highly antibiotic-resistant bacteria.

49 ent outcomes while reducing the emergence of resistant bacteria.

50 drugs or drug adjuvants to combat multidrug-resistant bacteria.

51 n of virulent toxin producing and antibiotic resistant bacteria.

52 acrophage function and killing of multi-drug resistant bacteria.

53 CF macrophage-mediated killing of antibiotic-resistant bacteria.

54 cytes during infections caused by antibiotic-resistant bacteria.

55 subsequent bloodstream infections caused by resistant bacteria.

56 as an alternative therapy against multidrug-resistant bacteria.

57 e a major disseminating source for multidrug resistant bacteria.

58 cs for use in the crisis of multi antibiotic-resistant bacteria.

59 n in-vivo and in-vitro efficacy against drug-resistant bacteria.

60 pproach for detection of live, dead and drug-resistant bacteria.

61 severe infections caused by extensively drug-resistant bacteria.

62 rulent animal wound model infected with drug-resistant bacteria.

63 y effect targeting a wide range of multidrug resistant bacteria.

64 usand mass spectra collected from multi-drug-resistant bacteria.

65 ues for the control of pathogenic multi-drug resistant bacteria.

66 l students in the investigation of multidrug-resistant bacteria.

67 between live and dead as well as antibiotic resistant bacteria.

68 to combat the increasing spread of multidrug-resistant bacteria.

69 er radioresistens are well-known, multi-drug resistant bacteria.

70 (25.4% vs 1.9%, P < .001) and less often had resistant bacteria (5.2% vs 6.8%, P < .05).

71 (25.4% vs. 1.9%, p<0.001) and less often had resistant bacteria (5.2% vs. 6.8%, p<0.05).

72 nd use of antibiotics has led to the rise of resistant bacteria, a problem possibly exacerbated by in

73 pecially infection from the extensively drug-resistant bacteria, A. baumannii.

74 In the fight against drug-resistant bacteria, accurate and high-throughput detecti

75 ial transmission and dominance of antibiotic-resistant bacteria among cohoused untreated mice.

76 ng of the mini library against multiple drug-resistant bacteria and a panel of cancer cell lines iden

77 , thereby reducing the density of antibiotic-resistant bacteria and also reducing patient-to-patient

78 peptides with proved activity to antibiotic resistant bacteria and biofilms.

79 Therefore, it seems advisable to quantify resistant bacteria and characterize their MICs and resis

80 elected extended-spectrum beta-lactam (ESBL) resistant bacteria and genes in 12 hospital wastewater o

81 manure increase the density of antimicrobial resistant bacteria and genes in the environment.

82 omes leads to emergence of new antimicrobial-resistant bacteria and global dissemination of them and

83 ces, especially with the growth of multidrug-resistant bacteria and interest in the microbiome.

84 SA) is one of the most widespread antibiotic-resistant bacteria and is the leading cause of hospital-

85 g/mL) against both vancomycin-sensitive and -resistant bacteria and likely benefit from two independe

86 oth therapeutic agents against antimicrobial-resistant bacteria and nonchemical agents for detection

87 als into the aquatic environment selects for resistant bacteria and resistance genes and stimulates b

88 adult patients not colonized with antibiotic-resistant bacteria and reviewed them for adverse events

89 f conventional antibiotics to kill multidrug-resistant bacteria and superbugs.

90 ure has led to the development of antibiotic-resistant bacteria and the accumulation of antibiotics i

91 icrobials are urgently needed to combat drug-resistant bacteria and to overcome the inherent difficul

92 To address the increase of drug-resistant bacteria and widespread inappropriate use of a

93 ents are enriched in antibiotics, antibiotic resistant bacteria, and antibiotic resistance genes, and

94 ions in immunization practices, emergence of resistant bacteria, and changes in patterns of immune mo

95 ibitors against pathogenic fungi, antibiotic-resistant bacteria, and neoplastic mammalian cells.

96 The antibiotic-resistant bacteria (ARB) and antibiotic-resistant genes

97 th blood disorders colonized with antibiotic-resistant bacteria (ARB) are prone to systemic infection

98 However, risk quantification for antibiotic-resistant bacteria (ARB) has been hindered by the absenc

99 and global dissemination of these antibiotic-resistant bacteria (ARB) is fuelled by antibiotic select

100 tream infections (BSIs) caused by antibiotic-resistant bacteria (ARB) replace antibiotic-susceptible

101 ir efficiencies in removing three antibiotic-resistant bacteria (ARB), namely, blaNDM-1-positive Esch

102 r time, allows for development of antibiotic-resistant bacteria (ARB); b) identifying and describing

103 Emerging multidrug-resistant bacteria are a challenge for modern medicine,

104 Rationale: Infections caused by multidrug-resistant bacteria are a major clinical challenge.

105 Infections caused by drug-resistant bacteria are a major problem worldwide.

106 Multi-drug resistant bacteria are a persistent problem in modern he

107 Infections caused by antibiotic-resistant bacteria are a rising public health threat and

108 Antibiotic-resistant bacteria are a significant threat to human hea

109 The emergence and spread of antibiotic-resistant bacteria are aggravated by incorrect prescript

110 Antibiotic-resistant bacteria are associated with increased patient

111 of the ETT and the development of multidrug-resistant bacteria are considered the primary causes of

112 g septic emergency department patients, drug-resistant bacteria are covered infrequently.

113 Infections caused by resistant bacteria are nowadays too common, and some pat

114 Among these amoeba resistant bacteria are numerous members of the genus Myc

115 interactions with carbapenems, as carbapenem-resistant bacteria are of grave clinical concern and car

116 Resistant bacteria are one of the leading causes of hosp

117 Multidrug-resistant bacteria are responsible for substantial morbi

118 The emergence and spread of multidrug resistant bacteria are widely believed to endanger human

119 Drug resistant bacteria are winning the fight over antibiotic

120 y pathogenic bacteria, especially antibiotic-resistant bacteria, are one of the biggest threats to gl

121 emergence of deadly pathogens and multidrug-resistant bacteria at an alarmingly increased rate, bact

122 t/control), R1, and R4 inhibited susceptible/resistant bacteria at concentrations ranging from 2 to 3

123 tible lineage 2 strain will harbor multidrug-resistant bacteria at the time of diagnosis.

124 sidues are not only conserved in WT and drug-resistant bacteria but also significant in enzymatic act

125 risk areas for transmission of antimicrobial-resistant bacteria, but no controlled study has tested t

126 he National Action Plan to Combat Antibiotic Resistant Bacteria calls for all US hospitals to improve

127 chanism by which drug-target interactions in resistant bacteria can be enhanced.

128 biotics for combination therapy against drug resistant bacteria can be realized on an integrated micr

129 ental releases of antibiotics and antibiotic-resistant bacteria can in many cases be reduced at littl

130 within bacterial consortia, where antibiotic-resistant bacteria can provide antibiotic-sensitive neig

131 In theory, these phenotypically resistant bacteria can retard the rate of microbiologica

132 ting of empiric antimicrobials for multidrug-resistant bacteria, Candida species, methicillin-resista

133 tion in Deinococcus radiodurans, a radiation-resistant bacteria capable of accumulating high concentr

134 r Disease Control and Prevention, antibiotic-resistant bacteria cause at least 2 million illnesses an

135 Antibiotic-sensitive and -resistant bacteria coexist in natural environments with

136 The emergence of multidrug resistant bacteria compounded by the depleting arsenal o

137 Our strategy to combat resistant bacteria consisted of targeting the GyrB/ParE

138 uld provide new antibiotic functions against resistant bacteria, contain disordered N-terminal transl

139 ritically important, especially as multidrug-resistant bacteria continue to emerge.

140 otics due to the urgent threat of antibiotic resistant bacteria coupled with the reduced effort in de

141 The ruthless selection for resistant bacteria, coupled with insufficient investment

142 The heavy metal-resistant bacteria Cupriavidus metallidurans CH34 relies

143 ut of ten antibiotics, the odds of detecting resistant bacteria decreased by ~ 32% (odds ratios, OR 0

144 Prevalence of culturable TCS-resistant bacteria decreased over time following Food an

145 n proteins, lipids, and nucleic acids of the resistant bacteria described in this study.

146 n, the growth of wild type bacteria and drug resistant bacteria differ significantly.

147 ene amplification is very low and antibiotic-resistant bacteria display no cross-resistance to these

148 The increasing prevalence of antimicrobial-resistant bacteria drives the need for advanced methods

149 +) bacteria (e.g., S. aureus) and antibiotic-resistant bacteria (e.g., MRSA).

150 e infection and the likelihood of antibiotic-resistant bacteria emerging and ascending.

151 The emergence of multidrug-resistant bacteria emphasizes the urgent need for novel

152 ntibiotics or strategies to combat multidrug resistant bacteria, especially Gram-negative bacteria fo

153 Infections caused by antibiotic-resistant bacteria, especially the "ESKAPE" pathogens, c

154 supplemented with chloramphenicol (Cm) when resistant bacteria expressing Cm acetyltransferase (CAT)

155 from this research suggested that antibiotic resistant bacteria expressing OMP TolC could spread more

156 antibiotics are rendered ineffective by drug-resistant bacteria, focus must be shifted towards altern

157 gulls are mobile and can shed antimicrobial-resistant bacteria for extended periods, gulls may facil

158 Induction resulted in rapid exclusion of resistant bacteria from mixed populations of antibiotic-

159 n vitro potency against pathogenic multidrug-resistant bacteria, further development of several candi

160 The spread of multidrug resistant bacteria has become a global concern.

161 The continuous emergence of resistant bacteria has become a major worldwide health t

162 t years, the increasing number of antibiotic-resistant bacteria has become a serious health concern.

163 therapeutics against notoriously antibiotic-resistant bacteria has led to a quest for novel antibact

164 The rise of antibiotic-resistant bacteria has led to an urgent need for rapid d

165 The increase in antibiotic resistant bacteria has raised global concern regarding t

166 The rapid emergence of multidrug-resistant bacteria has renewed interest in developing an

167 iseases titled, Bed bugs as Vectors for Drug-Resistant Bacteria has sparked a renewed interest in bed

168 ide probes to electrically detect antibiotic resistant bacteria in a highly specific manner.

169 ted animals can contribute to persistence of resistant bacteria in agricultural environments.

170 rate the development and spread of multidrug-resistant bacteria in cirrhosis.

171 lonisation and transmission of antimicrobial-resistant bacteria in European ICUs.

172 bedding reservoir compared with shedding of resistant bacteria in faeces.

173 Diseases caused by antibiotic-resistant bacteria in hospitals are the outcome of compl

174 n on the clinical epidemiology of antibiotic-resistant bacteria in hospitals.

175 , and indicated that the higher frequency of resistant bacteria in manure-amended soil was attributab

176 The detection and transmission of antibiotic-resistant bacteria in pilgrims attending the Kumbh Mela

177 ndment induced a bloom of certain antibiotic-resistant bacteria in soil that was independent of antib

178 cystic fibrosis patients, highly antibiotic-resistant bacteria in the BCC have emerged as problemati

179 it may be further developed to fight against resistant bacteria in the clinic.

180 er understanding of how to manage antibiotic-resistant bacteria in the future.

181 Inoculation with Ni-resistant bacteria in the rhizosphere of L. emarginata h

182 portion of deaths attributable to antibiotic-resistant bacteria in the United States.

183 reased risk of community-acquired, quinolone-resistant bacteria in their offspring, by about 50%.

184 creased risk of community-acquired quinolone-resistant bacteria in their offspring, by about 50%.

185 Selection of resistant bacteria in vitro reveals that two of the pred

186 ocycline family, is active against multidrug-resistant bacteria including extended-spectrum beta-lact

187 tries to track patients who carry antibiotic-resistant bacteria, including carbapenem-resistant Enter

188 Infections caused by antibiotic-resistant bacteria, including carbapenem-resistant Enter

189 nst multidrug-resistant and extensively drug-resistant bacteria, including ESBL, carbapenem- and coli

190 antibiotic development in increasingly drug-resistant bacteria, including Mycobacterium tuberculosis

191 treatment of infections caused by multidrug resistant bacteria, including S. aureus.

192 ansfer leads to the elimination of multidrug-resistant bacteria, including Staphylococcus aureus and

193 kill clinical isolates of several multidrug-resistant bacteria-including those from the genera Acine

194 The emergence of antimicrobial resistant bacteria increases the risk of treatment failu

195 nergy will diminish as the frequency of drug-resistant bacteria increases.

196 urthermore, antibiotic treatment selects for resistant bacteria, increases opportunities for horizont

197 reased personal risk of acquiring antibiotic-resistant bacteria, independent of personal history of a

198 iated with a higher occurrence of antibiotic-resistant bacteria, indicating that AB treatment in wome

199 lternative strategy for overcoming multidrug-resistant bacteria-induced sepsis and opens up possibili

200 an be applied for the treatment of multidrug-resistant bacteria-induced sepsis in mice with immunosup

201 al sources rarely contribute to the entry of resistant bacteria into the community.

202 ize the levels of antibiotics and antibiotic-resistant bacteria introduced into the environment.

203 prevalence of infections caused by multidrug-resistant bacteria is a global health problem that has b

204 The rapid rise of multi-drug-resistant bacteria is a global healthcare crisis, and ne

205 well-tolerated therapies against antibiotic-resistant bacteria is a global public health problem lea

206 The spread of antibiotic resistant bacteria is a global threat that shakes the fo

207 The increasing prevalence of antibiotic-resistant bacteria is a global threat to public health.

208 The widespread development of multidrug-resistant bacteria is a major health emergency.

209 The emergence of antibiotic resistant bacteria is a major threat to the practice of

210 nce in living cells while fighting multidrug-resistant bacteria is a paramount topic.

211 -to-patient transmission of these antibiotic-resistant bacteria is a perpetual concern in hospitals.

212 The emergence of antimicrobial-resistant bacteria is an increasingly serious threat to

213 Tracking the nosocomial spread of resistant bacteria is critical to infection control.

214 Surveillance of drug-resistant bacteria is essential for healthcare providers

215 important and emergent classes of multidrug-resistant bacteria is extended-spectrum beta-lactamase-p

216 Although the emergence of phage-resistant bacteria is likely inevitable, there is a grow

217 The emergence of multi-drug resistant bacteria is limiting the effectiveness of comm

218 The increase in multi-drug-resistant bacteria is limiting the effectiveness of curr

219 e prevalence and proliferation of antibiotic resistant bacteria is profoundly important to human heal

220 With the advent of drug-resistant bacteria, it is necessary to understand the fu

221 cribed risk factors for infections caused by resistant bacteria looking only at the index infection.

222 ission of infectious diseases and antibiotic-resistant bacteria, mass casualty incidents, and non-com

223 Infections by multidrug-resistant bacteria (MDRB) remain a leading cause of morb

224 a (Gram-positive and Gram-negative) and drug-resistant bacteria (methicillin-resistant Staphylococcus

225 nst both vancomycin-sensitive and vancomycin-resistant bacteria (MICs = 0.06-0.005 and 0.5-0.06 mug/m

226 imicrobial properties and inhibit antibiotic-resistant bacteria (MRSA and Pseudomonas aeruginosa), th

227 Network provides annual reports on monitored resistant bacteria, national surveillance efforts are st

228 ealthcare personnel (HCP) acquire antibiotic-resistant bacteria on their gloves and gowns when caring

229 therapy, chronic colonization with multidrug-resistant bacteria, or moribund status were excluded.

230 howed more often colonization with multidrug resistant bacteria (P = 0.02).

231 nging to resolve when infected by antibiotic-resistant bacteria, particularly methicillin-resistant S

232 washing reduced acquisition of antimicrobial-resistant bacteria, particularly MRSA.

233 The primary outcome was acquisition of resistant bacteria per 100 patient-days at risk, for whi

234 t one patient death was lowest for multidrug-resistant bacteria (PNNT = 20) followed by Candida speci

235 tam specificity and metal content.Carbapenem-resistant bacteria pose a major health threat by express

236 Multidrug-resistant bacteria pose a serious health threat, especia

237 The spread of antibiotic-resistant bacteria poses a global threat to public healt

238 The spread of antibiotic-resistant bacteria poses a substantial threat to morbidi

239 The increase in antibiotic resistant bacteria poses a threat to the continued use o

240 Antibiotic-resistant bacteria present an ongoing challenge to both

241 ), blaNDM-1 (r = 0.934, p = 0.009), and ESBL-resistant bacteria (r = 0.913, p = 0.010) levels across

242 theory of competitive release predicts, drug-resistant bacteria replicate fastest when their drug-sus

243 Infections due to multidrug-resistant bacteria represent a major global health chall

244 Drug-resistant bacteria represent a significant global threat

245 Infections caused by multidrug resistant bacteria represent a therapeutic challenge bot

246 s for infections caused by highly antibiotic-resistant bacteria represents a new, and as yet, unteste

247 he global strategy should include antibiotic-resistant bacteria responsible for community-acquired in

248 acterial growth, especially against the drug-resistant bacteria Salmonella typhimurium.

249 ational Action Plan for Combating Antibiotic-Resistant Bacteria set a goal of reducing inappropriate

250 e of antibiotic consumption in a population, resistant bacteria should completely eliminate non-resis

251 natural products with activity against drug-resistant bacteria showed that 60% of the compounds have

252 hypoxia and the appearance of the multidrug resistant bacteria Staphylococcus simulans in the fetal

253 s against two clinically isolated multi-drug-resistant bacteria strains (including carbapenem-resista

254 AIs) and the increasing number of antibiotic-resistant bacteria strains remain significant public hea

255 evidence of their efficacy against multidrug-resistant bacteria such as Enterobacteriaceae spp, Pseud

256 so showed high activity against various drug-resistant bacteria such as methicillin-resistant Staphyl

257 cluding drugs and vaccines against multidrug-resistant bacteria such as Neisseria gonorrhoeae The fir

258 contained a higher abundance of beta-lactam-resistant bacteria than soil treated with inorganic fert

259 inical care has driven the emergence of drug-resistant bacteria that are adapted to thrive in hospita

260 antibiotics has led to the evolution of drug-resistant bacteria that are becoming increasingly danger

261 outcomes, and to tackle the global threat of resistant bacteria that cause these infections.

262 the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes

263 Due to the rapid emergence of antibiotic-resistant bacteria, there is a growing need to discover

264 With rapid emergence of multidrug-resistant bacteria, there is often a need to perform sus

265 ion analysis method to prioritise antibiotic-resistant bacteria; this method involved the identificat

266 ient, there was no evidence for emergence of resistant bacteria to any of the tested antibiotics (inc

267 a National Action Plan to Combat Antibiotic-Resistant Bacteria to curb the rise of "superbugs," bact

268 o human pathogens, to decrease the spread of resistant bacteria to people and animals via foodstuffs,

269 o create a priority list of other antibiotic-resistant bacteria to support research and development o

270 hemicals) and microbes (including antibiotic-resistant bacteria) to receiving environments.

271 The results indicated that, antibiotic resistant bacteria turned the methylene blue in to white

272 le for acquired resistance but essential for resistant bacteria under therapeutic concentrations of a

273 shing molecular features of lead and cadmium resistant bacteria using Attenuated Total Reflectance-Fo

274 The final priority ranking of the antibiotic-resistant bacteria was established after a preference-ba

275 At day 7, no increase in resistant bacteria was identified.

276 Considering the current dilemma of multidrug-resistant bacteria we consider it particularly prudent t

277 eration cephalosporin against AmpC-producing resistant bacteria, we designed a novel broad-spectrum n

278 To discover reagents to fight against resistant bacteria, we initiated a chemical approach by

279 d hygiene on the prevalence of antimicrobial-resistant bacteria, we surveyed households in two rural

280 For trends in acquisition of antimicrobial-resistant bacteria, weekly incidence rate ratio (IRR) wa

281 In 13% of the patients, resistant bacteria were found during prophylactic treatm

282 ciated pneumonia, and infection by multidrug-resistant bacteria were independently associated to incr

283 althcare worker contamination with multidrug-resistant bacteria were positive environmental cultures

284 mortality, and the development of antibiotic-resistant bacteria, were reported.

285 do not reduce acquisition rates of multidrug-resistant bacteria, whether or not screening is done wit

286 re needed to treat infections caused by drug-resistant bacteria, which constitute a major growing thr

287 ming of lytic phages to kill only antibiotic-resistant bacteria while protecting antibiotic-sensitize

288 ients, such as those infected with multidrug-resistant bacteria, who were not included in earlier pha

289 This additional cost suggests that resistant bacteria will be outcompeted by susceptible ba

290 lar to antibiotics, the development of phage-resistant bacteria will halt clinical phage therapy.

291 ted mice that were colonized with ampicillin-resistant bacteria with a virulent strain of C. difficil

292 bations that can enhance the killing of drug-resistant bacteria with antibiotic treatment.

293 rectly monitor the phenotypic switch in drug-resistant bacteria with temporal resolution.

294 rototype for point-of-care diagnosis of drug resistant bacteria with visual signal output.

295 potently active against pathogenic and drug-resistant bacteria, with minimal inhibitory concentratio

296 effective at preventing spread of antibiotic-resistant bacteria within hospitals.

297 Antimicrobial-resistant bacteria within wastewater may reflect the res

298 iminate intestinal colonization by multidrug-resistant bacteria, without profound disruption of the i

299 Increase in drug-resistant bacteria worldwide and the dearth of new antib

300 as contributed to the emergence of multidrug resistant bacteria worldwide.